The burgeoning digital marketplace has presented novel avenues for accessing prescription medications, including the stimulant Adderall, primarily administered for attention deficit hyperactivity disorder (ADHD). While advocates of cognitive enhancement argue that these substances can augment focus and productivity, ethical concerns surge surroundi